This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsDividendFDA EventsHeadlinesOptions ChainTrendsBuy This Stock SVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period SINOVAC Board Sets the Record Straight on July 8 Special Meeting of ...July 13 at 3:45 AM | morningstar.comMSINOVAC Board of Directors Provides Update on Status of US$55.00 ...July 11 at 12:08 AM | morningstar.comMSINOVAC Board Sets the Record Straight on July 8 Special Meeting of ShareholdersJuly 11 at 4:21 PM | businesswire.comSinovac Biotech’s New Board Charts Future Path with Strategic InitiativesJuly 11 at 6:35 AM | tipranks.comNewly Elected Directors of Sinovac Hold the First Board MeetingJuly 10 at 7:45 AM | financialpost.comFNewly Elected Directors of Sinovac Hold the First Board MeetingJuly 10 at 7:23 AM | businesswire.comFinal Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2 - NasdaqJuly 9, 2025 | nasdaq.comSINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former BoardJuly 9, 2025 | businesswire.comSINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend PaymentJuly 9, 2025 | businesswire.comSINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE SharesJuly 9, 2025 | businesswire.comAppeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder VoteJuly 9, 2025 | businesswire.comSinovac Biotech Retains Support from Proxy Advisors Ahead of Crucial VoteJuly 8, 2025 | tipranks.comFinal Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2July 7, 2025 | finance.yahoo.comFinal Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2July 7, 2025 | businesswire.comFederal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVACJuly 7, 2025 | finance.yahoo.comFederal Court in Massachusetts Denies Vivo Capital's Petition for Relief on SINOVACJuly 7, 2025 | businesswire.comLeading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in PlaceJuly 3, 2025 | businesswire.comUnited States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding SinovacJuly 2, 2025 | businesswire.comSAIF Partners: Now is Your Last Chance to Vote for Board Change at SinovacJuly 2, 2025 | businesswire.comLeading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in PlaceJuly 2, 2025 | businesswire.comSAIF Partners Sends Letter to Sinovac ShareholdersJuly 1, 2025 | businesswire.comSINOVAC Board of Directors Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC's Current BoardJune 30, 2025 | businesswire.comSINOVAC Board of Directors Prevails Against Advantech/Prime's Lawsuit in Hong KongJune 27, 2025 | businesswire.comSeeking a Cure for Sickly Corporate Governance at SinoVacJune 26, 2025 | finance.yahoo.comSINOVAC Board of Directors Files Investor Presentation Outlining Decisive Actions to Protect Shareholder InterestsJune 24, 2025 | tmcnet.comSAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board’s Failure to Act in the Interests of ShareholdersJune 24, 2025 | theglobeandmail.comSinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 DividendJune 23, 2025 | msn.comPrime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special MeetingJune 21, 2025 | businesswire.comSINOVAC Board of Directors Prevails Against Advantech/Prime's New York LawsuitJune 20, 2025 | businesswire.comSINOVAC Board of Directors Files Definitive Proxy MaterialsJune 18, 2025 | businesswire.comSINOVAC Announces New Board MemberJune 18, 2025 | businesswire.comSINOVAC Board of Directors Provides Update on Special Dividend Payment and Commitment to Delivering Value to All ShareholdersJune 17, 2025 | businesswire.comPrime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech’s Current BoardJune 17, 2025 | finance.yahoo.comHeng Ren urges Sinovac board to pay $55 cash dividend before July 8 voteJune 17, 2025 | finance.yahoo.comPrime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech's Current BoardJune 16, 2025 | businesswire.comSAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the BoardJune 16, 2025 | businesswire.comSINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid ShareholdersJune 16, 2025 | businesswire.comPrime Success Responds to Sinovac Biotech's False and Misleading ClaimsJune 13, 2025 | businesswire.comSINOVAC's Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All ShareholdersJune 12, 2025 | businesswire.comVivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company’s False and Misleading ClaimsJune 11, 2025 | finance.yahoo.comVivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company's False and Misleading ClaimsJune 11, 2025 | businesswire.comPrime Success Sends Letter to Sinovac Biotech ShareholdersJune 10, 2025 | businesswire.comSINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual ReportMay 22, 2025 | businesswire.comSinovac Biotech Calls Special Shareholder Meeting Amid Board ReshuffleMay 20, 2025 | tipranks.comSinovac Responds To Vivo's Hostile Actions And LawsuitsApril 30, 2025 | nasdaq.comSINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo CapitalApril 29, 2025 | businesswire.comSinovac Biotech shareholder announces legal proceedings regarding boardApril 24, 2025 | markets.businessinsider.comSinovac Not To Meet Annual Report Filing Deadline With SEC As Auditor Resigns; Calls For New BoardApril 23, 2025 | nasdaq.comVivo Capital Files Lawsuits to Protect Sinovac Shareholders from the New Board's Value Destructive ActionsApril 23, 2025 | businesswire.comSINOVAC Management Statement Regarding Auditor ResignationApril 21, 2025 | globenewswire.com Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address SVA Media Mentions By Week SVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVA News Sentiment▼0.000.99▲Average Medical News Sentiment SVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVA Articles This Week▼171▲SVA Articles Average Week Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XENE News MIRM News IBRX News ARWR News APLS News TWST News LGND News APGE News DNLI News VCEL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SVA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SVA Stock Alerts